Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
International Journal of Laboratory Hematology
|
January 10, 2018
Comparison of five specific assays for determination of dabigatran plasma concentrations in patients enrolled in the START-Laboratory Register
M Cini, C Legnani, B Cosmi, et al.
Journal of Vascular Surgery
|
August 25, 2000
High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm
T Brunelli, D Prisco, S Fedi, et al.
Transplantation Proceedings
|
June 11, 2010
Lower homocysteine levels in renal transplant recipients treated with everolimus: a possible link with a decreased cardiovascular risk?
S Farsetti, M Zanazzi, L Caroti, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
November 21, 2000
Angiotensin-converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinemia increase first-trimester fetal-loss susceptibility
C Fatini, F Gensini, B Battaglini, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
December 9, 2000
Risk factors for cardiovascular disease in renal transplant recipients: new insights
R Marcucci, M Zanazzi, E Bertoni, et al.
Heart (British Cardiac Society)
|
July 5, 2005
PAI-1 and homocysteine, but not lipoprotein (a) and thrombophilic polymorphisms, are independently associated with the occurrence of major adverse cardiac events after successful coronary stenting
R Marcucci, D Brogi, F Sofi, et al.
International Journal of Cardiology
|
November 5, 2020
Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry
P Gresele, G Guglielmini, M Del Pinto, et al.
Journal of Thrombosis and Thrombolysis
|
March 11, 2023
Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy
M Berteotti, A M Gori, B Giusti, et al.
Thrombosis and Haemostasis
|
March 16, 2013
Reticulated platelets predict cardiovascular death in acute coronary syndrome patients. Insights from the AMI-Florence 2 Study
F Cesari, R Marcucci, A M Gori, et al.
Journal of Nephrology
|
April 3, 2001
Hyperhomocysteinemia in renal transplant patients: an independent factor of cardiovascular disease
E Bertoni, R Marcucci, M Zanazzi, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
International Journal of Laboratory Hematology
|
January 10, 2018
Comparison of five specific assays for determination of dabigatran plasma concentrations in patients enrolled in the START-Laboratory Register
M Cini, C Legnani, B Cosmi, et al.
Journal of Vascular Surgery
|
August 25, 2000
High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm
T Brunelli, D Prisco, S Fedi, et al.
Transplantation Proceedings
|
June 11, 2010
Lower homocysteine levels in renal transplant recipients treated with everolimus: a possible link with a decreased cardiovascular risk?
S Farsetti, M Zanazzi, L Caroti, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
November 21, 2000
Angiotensin-converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinemia increase first-trimester fetal-loss susceptibility
C Fatini, F Gensini, B Battaglini, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
December 9, 2000
Risk factors for cardiovascular disease in renal transplant recipients: new insights
R Marcucci, M Zanazzi, E Bertoni, et al.
Heart (British Cardiac Society)
|
July 5, 2005
PAI-1 and homocysteine, but not lipoprotein (a) and thrombophilic polymorphisms, are independently associated with the occurrence of major adverse cardiac events after successful coronary stenting
R Marcucci, D Brogi, F Sofi, et al.
International Journal of Cardiology
|
November 5, 2020
Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry
P Gresele, G Guglielmini, M Del Pinto, et al.
Journal of Thrombosis and Thrombolysis
|
March 11, 2023
Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy
M Berteotti, A M Gori, B Giusti, et al.
Thrombosis and Haemostasis
|
March 16, 2013
Reticulated platelets predict cardiovascular death in acute coronary syndrome patients. Insights from the AMI-Florence 2 Study
F Cesari, R Marcucci, A M Gori, et al.
Journal of Nephrology
|
April 3, 2001
Hyperhomocysteinemia in renal transplant patients: an independent factor of cardiovascular disease
E Bertoni, R Marcucci, M Zanazzi, et al.
Page
of 6